Synergy CHC与McKesson Canada和其他公司达成零售协议

2025-07-14 21:22

Synergy CHC (NASDAQ:SNYR) announced on Monday a new wave of retail and distribution wins across its FOCUSfactor supplement and functional beverage lines.
London Drugs, one of Canada’s most trusted pharmacy and retail chains, will launch FOCUSfactor brain health supplements across all 80 store locations in Western Canada beginning this summer.
The rollout introduces the brand’s clinically studied cognitive health formulas to a growing health and wellness consumer base.
FOCUSfactor has secured a national distribution agreement with McKesson Canada, the country’s largest pharmaceutical distributor.
Through this partnership, the brand will gain access to thousands of pharmacy and health-focused retail locations across Canada, including McKesson-operated banners and independent accounts. The rollout is scheduled for Q4 2025.
Gabe’s, an off-price retailer with 137 stores across the Mid-Atlantic and Southeast, will introduce FOCUSfactor Focus + Energy beverages to stores beginning later this summer.
Synergy CHC (NASDAQ:SNYR) shares were up more than 5% in premarket trading.

More on Synergy CHC